Form 4: Semler Scientific Director Natalie Brunell Acquires Stock Options

Natalie Brunell, a director at Semler Scientific, Inc., acquired stock options on May 15, 2025, as reported in a Form 4 filing with the SEC.

Summary

• Natalie Brunell, a director of Semler Scientific, Inc., reported changes in beneficial ownership to the SEC on May 22, 2025.
• The report details the acquisition of stock options on May 15, 2025.
• Brunell acquired options to purchase 7,500 shares of common stock at an exercise price of $31.79, vesting monthly after the grant date, expiring on 05/15/2035.
• Additionally, Brunell acquired options to purchase 1,875 shares of common stock at an exercise price of $31.79, vesting monthly after the grant date, expiring on 03/15/2027.
• Following these transactions, Brunell directly owns options for 9,375 shares.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The acquisition of stock options could be interpreted as a slightly positive signal, but it's a routine event.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers.

Stakeholder Impact

• The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Semler Scientific, Stock Options, Form 4, Director, Beneficial Ownership, SMLR